Exagen (XGN) Net Cash Flow (2018 - 2026)
Exagen filings provide 9 years of Net Cash Flow readings, the most recent being -$10.7 million for Q1 2026.
- On a quarterly basis, Net Cash Flow rose 1.25% to -$10.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.3 million, a 164.2% increase, with the full-year FY2025 number at $10.2 million, up 170.44% from a year prior.
- Net Cash Flow hit -$10.7 million in Q1 2026 for Exagen, down from -$3.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $18.8 million in Q2 2025 to a low of -$20.7 million in Q2 2023.
- Median Net Cash Flow over the past 5 years was -$6.3 million (2022), compared with a mean of -$4.6 million.
- The widest YoY moves for Net Cash Flow: up 775.72% in 2025, down 343300.0% in 2025.
- Exagen's Net Cash Flow stood at -$6.3 million in 2022, then soared by 227.44% to $8.0 million in 2023, then tumbled by 99.99% to $1000.0 in 2024, then tumbled by 343300.0% to -$3.4 million in 2025, then plummeted by 211.98% to -$10.7 million in 2026.
- The last three reported values for Net Cash Flow were -$10.7 million (Q1 2026), -$3.4 million (Q4 2025), and $5.6 million (Q3 2025) per Business Quant data.